Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078252 | SCV000110090 | uncertain significance | not provided | 2017-12-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000546348 | SCV000631937 | pathogenic | Glutaric aciduria, type 1 | 2023-11-19 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 143 of the GCDH protein (p.Val143Ala). This variant is present in population databases (rs141456457, gnomAD 0.005%). This missense change has been observed in individual(s) with glutaric acidemia I (GA1) (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 92531). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GCDH protein function. For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000546348 | SCV000792548 | uncertain significance | Glutaric aciduria, type 1 | 2017-06-30 | criteria provided, single submitter | clinical testing |